Graham Mecredy

Treatment outcomes after initiating buprenorphine/naloxone or methadone for opioid use disorder among First Nation Peoples in Ontario, Canada

Background The Canadian opioid toxicity crisis has disproportionately harmed First Nation Peoples. We compared opioid agonist treatment (OAT) outcomes within this population. Methods Our population-based cohort included First Nation Peoples in Ontario, Canada, who initiated bupre...